Savara
SVRA
180 hedge funds and large institutions have $1.34B invested in Savara in 2026 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 70 increasing their positions, 58 reducing their positions, and 26 closing their positions.
61% more call options, than puts
Call options by funds: $1.11M | Put options by funds: $687K
21% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 58
15% more capital invested
Capital invested by funds: $1.16B → $1.34B (+$179M)
2.26% more ownership
Funds ownership: 103.69% → 105.95% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
4% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 26
3% less funds holding
Funds holding: 185 → 180 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$17.8M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$9.35M |
| 3 |
BlackRock
New York
|
+$6.46M |
| 4 |
VA
VR Adviser
New York
|
+$5.4M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
+$2.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$7.62M |
| 2 |
SCM
Superstring Capital Management
New York
|
-$3.27M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.89M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.53M |
| 5 |
Jane Street
New York
|
-$2.31M |
SVRA Hedge Fund Activity: Q2 2026 in Review
180 of the 8,351 institutional investors tracked by Wall St. Rank reported a position in Savara (SVRA) for Q2 2026, worth a combined $1.34B — up 15% from $1.16B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of SVRA and 25 opened new positions — a net loss of 1 holder — while 58 trimmed existing stakes and 70 added.
The largest buyer was OrbiMed, adding an estimated $17.8M. The largest seller was Morgan Stanley, cutting an estimated $7.62M.
- 180 institutional investors held Savara (SVRA) as of Q2 2026, down from 185 in Q1 2026.
- Funds reported $1.34B of Savara stock for Q2 2026, up 15% quarter-over-quarter.
- 25 funds opened new Savara positions in Q2 2026 and 26 closed out, a net change of -1 holder.
- The largest Savara buyer in Q2 2026 was OrbiMed, an estimated $17.8M added.
- The largest Savara seller in Q2 2026 was Morgan Stanley, an estimated $7.62M sold.
Based on aggregated 13F filings for Q2 2026.